Using an RNAi Signature Assay to Guide the Design of Three-Drug-Conjugated Nanoparticles With Validated Mechanisms, in Vivo Efficacy, and Low Toxicity

Journal of the American Chemical Society - United States
doi 10.1021/jacs.6b06321

Related search